BOUNDLESS BIO
Boundless Bio is a company that develops novel cancer therapeutics intended to understand and treat intraceable cancers. It aims to be the foremost biopharma company interrogating extrachromosomal DNA (ecDNA) biology to deliver transformative therapies to patients with previously intractable cancers.
BOUNDLESS BIO
Industry:
Biotechnology Health Care Life Science Therapeutics
Founded:
2018-01-01
Address:
La Jolla, California, United States
Country:
United States
Website Url:
http://www.boundlessbio.com
Total Employee:
51+
Status:
Active
Contact:
858-766-9912
Email Addresses:
[email protected]
Total Funding:
151.4 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default LetsEncrypt WordPress Domain Not Resolving Wordpress Plugins Mobile Non Scaleable Content Sitelinks Search Box
Similar Organizations
Acrivon Therapeutics
Acrivon Therapeutics is a precision oncology therapeutics company specializing in drug development through early clinical treatment success.
ALX Oncology
ALX Oncology is a preclinical stage biotechnology company developing innovative immuno-oncology therapies for cancer.
Enliven Therapeutics
Enliven Therapeutics is a precision oncology company developing small molecule therapies to extend and improve patient lives.
Scout Bio
Scout Bi is a biotechnology company that provides veterinary, animal health, and gene therapy.
Vigil Neuroscience
Vigil Neuroscience is a biotechnology company that develops novel therapeutics for neurodegenerative diseases.
Current Advisors List
Current Employees Featured
Founder
Investors List
Fidelity Management and Research Company
Fidelity Management and Research Company investment in Series B - Boundless Bio
Redmile Group
Redmile Group investment in Series B - Boundless Bio
Wellington Management
Wellington Management investment in Series B - Boundless Bio
PFM Health Sciences
PFM Health Sciences investment in Series B - Boundless Bio
Nextech Invest
Nextech Invest investment in Series B - Boundless Bio
Surveyor Capital
Surveyor Capital investment in Series B - Boundless Bio
RA Capital Management
RA Capital Management investment in Series B - Boundless Bio
Boxer Capital
Boxer Capital investment in Series B - Boundless Bio
GT Healthcare Capital Partners
GT Healthcare Capital Partners investment in Series B - Boundless Bio
Alexandria Venture Investments
Alexandria Venture Investments investment in Series B - Boundless Bio
Key Employee Changes
Official Site Inspections
http://www.boundlessbio.com Semrush global rank: 4.27 M Semrush visits lastest month: 2.71 K
- Host name: 141.193.213.21
- IP address: 141.193.213.21
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Boundless Bio"
Who We Are – Boundless Bio
Developing an entirely new class of therapeutics requires boldness, commitment, creativity, and an entrepreneurial spirit. We are building a team of pioneers committed to driving a scientific …See details»
Boundless Bio - Crunchbase Company Profile & Funding
Organization. Boundless Bio . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. ... Contact Email [email protected]; Phone Number 858-766-9912; Boundless Bio is a …See details»
Boundless Bio Company Overview, Contact Details & Competitors …
May 16, 2023 Career Inquiries [email protected] General Information Inquiries [email protected]. Sign up for free to view info. Email Format Employee directory . …See details»
Boundless Bio - LinkedIn
Boundless Bio is discovering and developing novel cancer therapeutics based on the role of extrachromosomal DNA (ecDNA) in driving tumorigenesis, resistance and recurrence.See details»
Boundless Bio Company Profile | Management and Employees List
[email protected]: Boundless Bio Top Competitors. Company Employees Revenue Top technologies; Volastra Therapeutics Inc. 35: $11.8 M: Dragonfly Therapeutics Inc. 114: $8.4 …See details»
Boundless Bio Company Profile 2024: Stock …
Boundless Bio General Information Description. Boundless Bio Inc is a clinical-stage oncology company. It is dedicated to unlocking a new paradigm in cancer therapeutics that addresses the significant unmet need in patients with …See details»
Company Boundless Bio, Inc. - MarketScreener.com
Nov 30, 2018 Boundless Bio, Inc.: Company profile, business summary, shareholders, managers, financial ratings, industry, sector and market information | Nasdaq: BOLD | NasdaqSee details»
Tales of a Startup: Boundless Bio - University of …
Feb 11, 2021 Unbound By Convention, Bound To Save Lives With Boundless Bio. February 11, 2021. Developing medicines to combat the role of ecDNA in aggressive cancers, the San Diego based therapeutics company Boundless …See details»
Boundless Bio - Company Profile - Tracxn
Nov 12, 2024 Boundless Bio ranks 7th among 252 active competitors. 101 of its competitors are funded while 60 have exited. Overall, Boundless Bio and its competitors have raised over …See details»
Leaps by Bayer
Approach. Boundless Bio is the first company committed to developing transformative therapeutics for patients with oncogene amplified cancers driven by extrachromosomal DNA (ecDNA). ecDNA are circular DNA, physically …See details»
Boundless Bio Information - RocketReach
We know that receiving support is energizing, and giving help is fulfilling. We are inspired by the patients who are reliant upon our success. At Boundless, we’re all in. We are unbound by …See details»
Boundless Bio - Overview, News & Similar companies - ZoomInfo
Apr 21, 2024 Boundless Bio contact info: Phone number: (858) 766-9912 Website: www.boundlessbio.com What does Boundless Bio do? Boundless Bio is a next-generation …See details»
Boundless Bio Announces $100 Million Oversubscribed
May 16, 2023 Boundless Bio Contact James Lee (Business Development) Email: [email protected] Leaps by Bayer Contact Kira Peikoff Deputy Communications …See details»
Boundless Bio - Work in biotech
Boundless Bio is developing therapeutics directed against extrachromosomal DNA (eDNA) to treat the most intractable cancers. ecDNAs are large units of circular DNA that reside within …See details»
Why We’re Here – Boundless Bio
When DNA in cancer cells comes off chromosomes in the form of extrachromosomal DNA (ecDNA), it becomes unbound and unwound, thereby enabling numerous copies of cancer …See details»
Boundless Bio - Craft
Boundless Bio is a developer of novel cancer therapeutics intended to understand and treat intractable cancers. It offers cancer drugs and extrachromosomal DNA (ecDNA) that eliminate …See details»
Working At Boundless Bio: Company Overview and Culture - Zippia
Boundlessbio.com. Organization Type. Private. Social Media. Boundless Bio is a company that develops novel cancer therapeutics intended to understand and treat intraceable cancers. It …See details»
Publications – Boundless Bio
Nov 6, 2024 We at Boundless Bio are pioneers in understanding and treating the most intractable cancers. We have charted a new spatial map of the cancer genome within cancer …See details»
What We Do – Boundless Bio
The Spyglass platform consists of a comprehensive suite of proprietary ecDNA+/- models that span many tumor types and amplified oncogenes. Leveraging innovative molecular analytical …See details»